Highlights and Quick Summary
- Total current liabilities for the quarter ending September 30, 2023 was $39.4 Million (a 37.06% increase compared to previous quarter)
- Year-over-year quarterly Total current liabilities increased by 47.36%
- Annual Total current liabilities for 2022 was $26.7 Million (a -53.93% decrease from previous year)
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total current liabilities of Prime Medicine, Inc.
Most recent Total current liabilitiesof PRME including historical data for past 10 years.Interactive Chart of Total current liabilities of Prime Medicine, Inc.
Prime Medicine, Inc. Total current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $39.37 | $28.72 | $23.87 | – | – |
| 2022 | – | – | $26.71 | $22.22 | $26.71 |
| 2021 | – | – | – | – | $57.98 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology